Odey Asset Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Odey Asset Management Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,000	Closed	-$4.24M	–	67
2021 Q3	$4.24M	Hold	7,000	–	–	1.13%	22
2021 Q2	$3.91M	Hold	7,000	–	–	0.88%	23
2021 Q1	$3.31M	Sell	7,000 -1,100	-14%	-$536K	0.93%	23
2020 Q4	$3.91M	Buy	8,100 +1,950	+32%	+$1.05M	1%	22
2020 Q3	$3.44M	Hold	6,150	–	–	0.47%	25
2020 Q2	$3.83M	Hold	6,150	–	–	0.66%	22
2020 Q1	$3M	Buy	+6,150	New	+$2.54M	0.5%	31
2019 Q3	–	Sell	-5,100	Closed	-$1.6M	–	64
2019 Q2	$1.6M	Hold	5,100	–	–	0.14%	48
2019 Q1	$2.09M	Sell	5,100 -3,100	-38%	-$1.28M	0.17%	44
2018 Q4	$3.06M	Hold	8,200	–	–	0.27%	37
2018 Q3	$3.31M	Hold	8,200	–	–	0.28%	34
2018 Q2	$2.83M	Buy	8,200 +2,173	+36%	+$680K	0.27%	30
2018 Q1	$2.08M	Hold	6,027	–	–	0.22%	38
2017 Q4	$2.27M	Sell	6,027 -440	-7%	-$178K	0.21%	36
2017 Q3	$2.89M	Hold	6,467	–	–	0.26%	40
2017 Q2	$3.18M	Buy	6,467 +3,267	+102%	+$1.43M	0.35%	32
2017 Q1	$1.24M	Hold	3,200	–	–	0.13%	50
2016 Q4	$1.18M	Hold	3,200	–	–	0.12%	48
2016 Q3	$1.29M	Sell	3,200 -2,800	-47%	-$1.12M	0.09%	59
2016 Q2	$2.1M	Buy	6,000 +4,000	+200%	+$1.54M	0.19%	47
2016 Q1	$721K	Buy	+2,000	New	+$824K	0.08%	58

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Odey Asset Management Group's REGN Position: Q4 2021 in Review

Odey Asset Management Group sold out of Regeneron Pharmaceuticals (REGN) in Q4 2021, closing a stake of 7,000 shares — an estimated $4.24M sold.

Odey Asset Management Group first reported a position in REGN in Q1 2016 and held it in 21 quarters. The position peaked at $4.24M in Q3 2021. 1,078 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Odey Asset Management Group reported no remaining Regeneron Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Odey Asset Management Group sold 7,000 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $4.24M.
Odey Asset Management Group first reported a position in Regeneron Pharmaceuticals in Q1 2016 and held it in 21 quarters.
Odey Asset Management Group's Regeneron Pharmaceuticals position peaked at $4.24M in Q3 2021.
1,078 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Odey Asset Management Group's 13F filing for Q4 2021, filed 14 Feb 2022.